利多卡因调控Keap1-Nrf2/HO-1信号通路对PE诱导心肌细胞肥大的影响

    Lidocaine mitigates phenylephrine-induced myocardial cell hypertrophy via the Keap1-Nrf2/HO-1 signaling pathway

    • 摘要:
      目的 探讨利多卡因调控Kelch样环氧氯丙烷相关蛋白1(Keap1)-核转录因子E2相关因子2( Nrf2)/血红素氧合酶-1(HO-1)信号通路对苯肾上腺素(PE)诱导心肌细胞肥大的影响。
      方法 大鼠心肌细胞H9C2细胞分为对照组、PE组、利多卡因低浓度组、利多卡因高浓度组、利多卡因高浓度+pcDNA组、利多卡因高浓度+Keap1激活剂(pcDNA-Keap1)组。CCK-8法检测细胞活力;比色法检测H9C2细胞培养上清液中乳酸脱氢酶(LDH)释放量;免疫荧光染色检测H9C2细胞面积;qRT-PCR检测H9C2细胞中心房利钠肽(ANP)、脑利钠肽(BNP)、β肌凝蛋白重链(β-MHC)mRNA表达;试剂盒检测H9C2细胞中丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)水平;Western blot检测H9C2细胞中Keap1、Nrf2、HO-1蛋白表达。利用从新生大鼠中分离出的原代心肌细胞对上述实验结论进行验证。
      结果 与对照组比较,PE组H9C2细胞活力、GSH-Px、SOD水平及Nrf2、HO-1蛋白降低,上清液中LDH释放量、H9C2细胞面积、ANP、β-MHC、BNP mRNA表达、MDA水平及Keap1蛋白升高(P<0.05);与PE组比较,利多卡因低浓度组、利多卡因高浓度组H9C2细胞活力、GSH-Px、SOD水平及Nrf2、HO-1蛋白升高,上清液中LDH释放量、H9C2细胞面积、ANP、β-MHC、BNP mRNA表达、MDA水平及Keap1蛋白降低(P<0.05);pcDNA Keap1逆转了利多卡因对PE诱导的H9C2细胞氧化应激及细胞肥大的影响;利多卡因可能通过下调Keap1激活Nrf2/HO-1通路抑制PE诱导的新生大鼠原代心肌细胞氧化应激,减轻细胞肥大。
      结论 利多卡因可能通过下调Keap1激活Nrf2/HO-1通路抑制PE诱导的心肌细胞氧化应激,减轻细胞肥大。

       

      Abstract:
      AIM To investigate the effects of lidocaine on phenylephrine (PE)-induced myocardial cell hypertrophy by regulating the Kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2 related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway.
      METHODS H9C2 rat myocardial cells were divided into six groups: control, PE, lidocaine low concentration, lidocaine high concentration, lidocaine high concentration + pcDNA, and lidocaine high concentration + Keap1 activator (pcDNA-Keap1). Cell viability was assessed using the CCK-8 assay. Lactate dehydrogenase (LDH) release in the cell supernatant was measured using a colorimetric method. Immunofluorescence staining was performed to evaluate the area of H9C2 cells. The mRNA levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and β-myosin heavy chain (β-MHC) were quantified by quantitative real-time PCR (QRT-PCR). The levels of malondialdehyde (MDA), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) in H9C2 cells were detected by the kit. Protein expression of Keap1, Nrf2, and HO-1 was analyzed by Western blot. Additionally, primary cardiomyocytes from neonatal rats were used to validate the findings.
      RESULTS Compared to the control group, the PE group exhibited reduced cell viability, GSH-Px, SOD levels, and Nrf2/HO-1 protein expression, while LDH release, H9C2 cell area, ANP, β-MHC, BNP mRNA levels, MDA, and Keap1 protein expression were significantly increased (P<0.05). Compared with the PE group, the H9C2 cell viability, GSH-Px, SOD levels, and Nrf2 and HO-1 proteins were increased in both lidocaine low and high concentration group, while the release of LDH in the supernatant, H9C2 cell area, ANP, β-MHC, BNP mRNA expression, MDA level, and Keap1 protein were reduced (P<0.05). PcDNA Keap1 reversed the effects of lidocaine on PE induced oxidative stress and cell hypertrophy in H9C2 cells. Similarly, lidocaine inhibited oxidative stress and attenuated hypertrophy in neonatal rat cardiomyocytes by downregulating the Keap1-activated Nrf2/HO-1 pathway.
      CONCLUSION Lidocaine alleviate PE-induced oxidative stress and myocardial cell hypertrophy by downregulating Keap1 and activating the Nrf2/HO-1 signaling pathway.

       

    /

    返回文章
    返回